Management team

 

Barbara Canepa

 

PhD, MBM, Test Facility Manager/Laboratory Manager

Biologist, she holds a PhD in “Human biology” followed by a II level Master in “Business and research management”. She is in charge of the coordination of R&D activities and she manages  the relationships between scientist teams and sponsors.
In 2002  she implemented the scientific unit at Bioindustry park with the Molecular and Cell biology area.
She studied and researched intensively in molecular and cell biology at the University of Turin. She carried on her doctorate in collaboration with Creabilis Therapeutics S.r.L, a pharmaceutical company settled in Bioindustry park.
She focused her investigations within the drug research and development process in therapeutic areas such as inflammation and rare diseases.
She is now  focusing  her research on development and validation of novel cell based assays and on biologic drugs R&D and analysis.

LinkedIn profile

Davide Corpillo

PhD, Head of Laboratory

Chemist, he holds a PhD in Biochemistry.
He is in charge of the Bioanalytics and Proteomics – Mass Spectrometry Lab management.
In 2000 he implemented the scientific unit at Bioindustry Park with the Proteomic area.
He studied and researched intensively in biochemistry at the University of Turin. He is specialized in Mass spectrometry applications for proteins and small molecules detection and quantification in complex matrices.
He focused his investigations within the drug research and development process in therapeutic areas such as neurodegenerative disorders.
He is now  focusing  his research on biologic drugs R&D and analysis through mass spectrometry in particular with MALDI Imaging technology.

LinkedIn profile

Sarah Dewilde

PhD, Head of Laboratory

Pharmacist, she holds a degree in  pharmaceutical biotechnology and a PhD in Human biology.
She is in charge of the Molecular and Cell Biology and Protein Biochemistry Lab management.
Prior to joining ABLE Biosciences she was researcher at Bionucleon S.r.L, a frontrunner start up concerned in novel nucleic acid-based therapeutic agents.
She studied  transcriptional pathways at the University of Turin.She focused her investigations within the drug research and development process in therapeutic areas such as cancer and inflammation.
She is now focusing her research on development and validation of novel cell based assays and on biological drugs R&D.

LinkedIn profile

Alessandra Giuliano Albo

PhD,  Quality Assurance Manager

Veterinary, she holds a PhD in “Animal toxicology and pharmacology” followed by an academic specialty in “Avian technology and pathology” and a II level master in “Medical statistics and statistics methods for epidemiology”. She is now attending the II level Master "Quality System: GxP and ISO" at Università Cattolica del Sacro Cuore – Facoltà di Medicina e Chirurgia - Rome.

In 2002 she joined the Bioindustry park scientific unit as biochemistry analyst and scientific consultant at business development e technology transfer office.

She focused her investigations within the drug research and development process in toxicology and pharmacology and in therapeutic areas such as neurodegeneration.
She is now  in charge of the Quality Assurance unit  Management of ABLE Biosciences Test facility.

LinkedIn profile